These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1302091)

  • 1. [Complications of prostatic biopsies. Analysis of a series of 4,764 biopsies].
    Aubert J
    Prog Urol; 1992 Jun; 2(3):484-7. PubMed ID: 1302091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transrectal prostatic biopsy: the role of preventive measures].
    Vaessen C; Janssen T; Schulman C
    Acta Urol Belg; 1997 Dec; 65(4):9-12. PubMed ID: 9497590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biopsy technique and biopsy schemes for a first series of prostatic biopsies].
    Villers A; Mouton D; Rébillard X; Chautard D; Ruffion A; Staerman F; Cornud F
    Prog Urol; 2004 Apr; 14(2):144-53. PubMed ID: 15217126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidural abscess after prostatic biopsies].
    Labarthe P; Laroche M; Massip P; Khedis M; Huyghe E; Plante P; Soulié M
    Prog Urol; 2005 Sep; 15(4):733-5. PubMed ID: 16459697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications of prostatic biopsy. An analysis of a series of 4764 biopsies].
    Delmas V; Billebaud T; Villers A; Boccon-Gibod L
    Prog Urol; 1993 Oct; 3(5):741. PubMed ID: 8130801
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?
    Zapatero A; Mínguez R; Nieto S; Martín de Vidales C; García-Vicente F
    Eur Urol; 2009 Apr; 55(4):902-9. PubMed ID: 18485578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients.
    Peyromaure M; Ravery V; Messas A; Toublanc M; Boccon-Gibod L; Boccon-Gibod L
    J Urol; 2002 Jan; 167(1):218-21. PubMed ID: 11743309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
    Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
    J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications following combined transrectal ultrasound-guided prostate needle biopsies and transurethral resection of the prostate.
    Shen BY; Chang PL; Lee SH; Chen CL; Tsui KH
    Arch Androl; 2006; 52(2):123-7. PubMed ID: 16443589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics prophylaxis for digital-guided transrectal tru-cut needle biopsy of the prostate.
    Eke N
    West Afr J Med; 2006; 25(4):262-5. PubMed ID: 17402511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic development of clinical practice guidelines for prostate biopsies: a 3-year Italian project.
    Bertaccini A; Fandella A; Prayer-Galetti T; Scattoni V; Galosi AB; Ficarra V; Trombetta C; Gion M; Martorana G;
    Anticancer Res; 2007; 27(1B):659-66. PubMed ID: 17348457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of aspiration and trephine biopsies in the diagnosis of prostatic cancer].
    Vorob'ev AV
    Vopr Onkol; 1982; 28(4):63-6. PubMed ID: 7090273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostate biopsies: how many samples and how many containers? Cost effectiveness].
    Molinié V; Mahjoub WK; Balaton A
    Ann Pathol; 2008 Oct; 28(5):424-8. PubMed ID: 19068397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biopsies of the transitional zone: impact on the detection of prostatic cancer and prognostic value].
    Peyromaure M; Ravery V; Boccon-Gibod L
    Prog Urol; 2002 Feb; 12(1):8-14. PubMed ID: 11980019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.
    Shigemura K; Yasufuku T; Yamashita M; Arakawa S; Fujisawa M
    Int J Urol; 2009 Sep; 16(9):723-5. PubMed ID: 19638042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results.
    Cohen JK; Miller RJ; Rooker GM; Shuman BA
    Urology; 1996 Mar; 47(3):395-401. PubMed ID: 8633408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
    Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
    J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transrectal biopsy of the prostate: a review of 186 biopsies.
    Awojobi OA; Junaid TA; Nkposong EO
    Afr J Med Med Sci; 1983; 12(3-4):117-9. PubMed ID: 6202128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathologic features of prostate cancer detected after repeat false-negative biopsy in a screening population.
    Steiner H; Moser P; Hager M; Berger AP; Klocker H; Spranger R; Rogatsch H; Bartsch G; Horninger W
    Prostate; 2004 Feb; 58(3):277-82. PubMed ID: 14743467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values.
    Keetch DW; Catalona WJ
    J Urol; 1995 Nov; 154(5):1795-7. PubMed ID: 7563349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.